UNSPSC 51273606: Articaine hydrochloride

This classification denotes an anesthetic agent with the molecular formula C13H20N2O3S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QS9014Q792, chemically known as 2-thiophenecarboxylic acid, 4-methyl-3-(2-(propylamino)propionamido)-, methyl ester, monohydrochloride but more generally known as articaine hydrochloride, which bears US NIH Compound Identifier 32169. European Medicines Agency schedules Articaine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00597MIG.

UNSPSC 51273606 Articaine hydrochloride is a Commodity code for a local anesthetic pharmaceutical product used primarily in dental and medical procedures. However, the recent state and local procurement activity recorded under this code does not align with articaine hydrochloride procurement — Seminole County, Florida's IFB60459723LAS solicitation targets naloxone (an opioid antagonist) and drug deactivation systems for community health initiatives, not articaine or dental anesthetics. The code shows little relevant recent activity aligned with its nominal pharmaceutical scope.

Seminole County Community Health Building in Sanford, Florida is the sole identified issuing body in the recent-opportunities record. The IFB, posted June 30, 2026, with a response deadline of July 26, 2023, seeks annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems, with quarterly deliveries and all shipping costs included in vendor proposals. The mismatch between the code's stated commodity (articaine hydrochloride) and the actual solicitation content suggests either a coding error in Seminole County's tagging or a data inconsistency — business development professionals should verify the correct UNSPSC classification for naloxone and drug deactivation systems procurement before pursuing similar opportunities.